Insmed reported $17.63M in Trade Debtors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acelrx Pharmaceuticals ACRX:US $ 658K 23K
Alexion Pharmaceuticals ALXN:US $ 1473M 63.7M
Alimera Sciences ALIM:US $ 15.7M 1.5M
Biomarin Pharmaceutical BMRN:US $ 424.42M 28.32M
Dynavax Technologies DVAX:US $ 83.99M 61.33M
Flexion Therapeutics FLXN:US $ 30.67M 398K
Gilead Sciences GILD:US $ 4149M 224M
Heron Therapeutics HRTX:US $ 38.52M 3.32M
Insmed INSM:US $ 17.63M 1.07M
Mirati Therapeutics MRTX:US $ 1.84M 0.47M
Novartis NVS:US $ 8654M 173M
Regeneron Pharmaceuticals REGN:US $ 4173M 58.3M
Sarepta Therapeutics SRPT:US $ 136.37M 2.22M
Seattle Genetics SGEN:US $ 379.74M 43.91M
Ultragenyx Pharmaceutical RARE:US $ 25.03M 1.94M
Vertex Pharmaceuticals VRTX:US $ 929.14M 48.41M